3
Total investments
0
Early stage
0
Mid stage
0
Late stage
2y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jan 2025
ProductSense turns scattered customer and market signals into clear evidence your team can act on.
We gather insights from every channel and use AI to reveal the patterns, opportunities, and problems that matter most. Product teams get a complete view, faster decisions, and plans grounded in truth instead of noise.
Trusted by B2B SaaS teams who want a modern alternative to manual spreadsheets or legacy product tools.
Capture everything. Understand what matters. Build with confidence.
Experience · 5 entries
All (5)
Investments (3)
2025
Investor
Jan 2025
ProductSense turns scattered customer and market signals into clear evidence your team can act on.
We gather insights from every channel and use AI to reveal the patterns, opportunities, and problems that matter most. Product teams get a complete view, faster decisions, and plans grounded in truth instead of noise.
Trusted by B2B SaaS teams who want a modern alternative to manual spreadsheets or legacy product tools.
Capture everything. Understand what matters. Build with confidence.
2024
Investor
Sep 2024
Our goal is simple: to streamline admin work so that vets can focus on what matters most - providing the best care possible for animals.
Investor
Jun 2024
We are an early-stage venture capital fund based in Amsterdam, Berlin, and Stockholm. We invest Europe-wide and have active investments in the Benelux, DACH, and Nordic regions. We are fully funded and ran by experienced entrepreneurs.
We value eye-to-eye conversation, transparency, and complete teams.
As investors, we specialize in models, rather than particular industries or verticals. We have more than a decade of experience in scaling marketplace, platform, and SaaS companies. Our sweet spot is pre Series-A
We are proud of our colorful portfolio of over 40 investments (and awesome founders!) with strong exits including IENS (exit to Tripadvisor in 2015), Radionomy (exit to Vivendi in 2016), CheapCargo (exit to PostNL in 2017), United Wardrobe (Exit to Vinted in 2020), and Catawiki.
If you are looking for an investor that is boots on the ground, please reach out to us via http://peak.capital/contact
2022
Visiting Analyst
Jun 2022
coparion is a venture capital fund for young, German technology companies. The capital is provided by ERP Special Fund, KfW Capital and European Investment Bank.
We accelerate growth: We help young technology companies achieve swift and sustained growth. With a fund sitze of EUR 275 million we have the means to do so.
We are your partner
: We support entrepreneurial vision with our know-how, but without intervening in daily business operations. Thanks to our long-standing experience in venture capital and in building companies, we discern potentials and open up new perspectives. We have the substance, tenacity and creativity required to mutually manage difficult situations successfully.
We are professional and steady: Due to our independence we are flexible, pragmatic, and able to act swiftly. All our decisions focus on increasing the value of our portfolio companies – always taking a long-term perspective bereft of any short-term opportunism.
We collaborate with strong partners: We only invest together with private investors. And focus primarily on shared values and quality standards.
_________________________________
Impressum:
https://coparion.vc/node/7
2020
Investment Team (Intern & Working Student)
Jan 2020
At SHS Capital we are committed to Building European Healthcare Champions, by helping to accelerate our portfolio companies growth. We do that by following high ethical and sustainable standards. If you are looking for the right partner to bring your Healthcare company to the next level, reach out!
https://www.shs-capital.eu/
We focus on
Phases: Growth cases and “Mittelstand” companies
Regions: DACH, Benelux, and the NordicsIndustries: Life science, Medical technology, Diagnostics, Digital health, Applied technologies, and industrial biotechnology & pharmaceuticals (no drug development)
Investors can participate in a diversified portfolio of innovative companies from the life science and medical technology sector via SHS funds. Our investor base comprises private and institutional investor groups with a long-term focus. We currently host investors from well-known family offices, pension funds, pension schemes, fund of funds, banks, churches, health insurance companies, industrial companies, the European Investment Fund, and the KfW.
Investment activity
2024–2025 · 3 investments
Recent (last 2 years)Earlier
